Updates

Volex - Strong Q1 trading

September 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

At the AGM, Volex said Q1 has been strong, and in line with management’s new 5-year growth plan. Sales are ahead by 4.9% (organic) whilst the acquisition pipeline being developed will reinforce growth prospects. In terms of end market exposures, the EV side has seen strong underlying demand from a growing range of products; Consumer Electrical revenues have continued to grow, as a result of new projects and increased market share; Medical’s demand remains robust and revenues are ahead of Q1 21; and finally, demand in the core business of Complex Industrial Technology is noted as strong with next-generation high speed cable volumes (400Gbs) expected to pick up strongly as replacement programmes accelerate. Singer forecasts ep ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Made Tech - Headcount rockets from 235 to 478

UP Global Sourcing

Volex - To benefit from Trump’s lower US tax and autonomous vehicles (December 2024)

Volex - Organic sales and margins ahead of expectations (November 2024)

Volex - Investment driven by localisation (August 2024)

Volex (May 2024)

Volex (December 2023)

Volex (November 2023)

Volex - Murat Ticaret deal completes earlier than anticipated (September 2023)

Volex - Transformational deal produces 14% eps upgrade (July 2023)

Volex - Trading ahead of expectations (May 2023)

Volex - Outperforming the market (December 2022)

Volex - To bust a billion within five years (July 2022)

Volex - EV demand helps it beat expectations (May 2022)

Volex - Enters EV infrastructure segment (December 2021)

Volex - Two directors buy shares (November 2021)

Volex - Earnings accretive US defence acquisition (September 2021)

Volex - Forecast up 5% as Medical and EV jump (August 2021)

Volex - Data centres and EV sales +38% and +193%, respectively (July 2021)

Volex - Significant beat on FY21 estimates (May 2021)

Volex (March 2021)

Volex - Three deals being worked on (January 2021)

Volex - Canaccord sets 398p price target (December 2020)

Volex - "Materially ahead of expectations"- results due on 12 November (November 2020)

Volex (August 2020)

Volex (May 2020)

Volex - High growth and exciting (December 2019)

Volex - Five quarters of improvement (June 2010)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X